152 research outputs found
Attribution Required: Stack Overflow Code Snippets in GitHub Projects
Stack Overflow (SO) is the largest Q&A website for developers, providing a
huge amount of copyable code snippets. Using these snippets raises various
maintenance and legal issues. The SO license requires attribution, i.e.,
referencing the original question or answer, and requires derived work to adopt
a compatible license. While there is a heated debate on SO's license model for
code snippets and the required attribution, little is known about the extent to
which snippets are copied from SO without proper attribution. In this paper, we
present the research design and summarized results of an empirical study
analyzing attributed and unattributed usages of SO code snippets in GitHub
projects. On average, 3.22% of all analyzed repositories and 7.33% of the
popular ones contained a reference to SO. Further, we found that developers
rather refer to the whole thread on SO than to a specific answer. For Java, at
least two thirds of the copied snippets were not attributed.Comment: 3 pages, 1 figure, Proceedings of the 39th International Conference
on Software Engineering Companion (ICSE-C 2017), IEEE, 2017, pp. 161-16
iManageMyHealth and iSupportMyPatients: mobile decision support and health management apps for cancer patients and their doctors
Clinical decision support systems can play a crucial role in healthcare delivery as they promise to improve health outcomes and patient
safety, reduce medical errors and costs and contribute to patient satisfaction. Used in an optimal way, they increase the quality of healthcare
by proposing the right information and intervention to the right person at the right time in the healthcare delivery process.
This paper reports on a specific approach to integrated clinical decision support and patient guidance in the cancer domain as proposed
by the H2020 iManageCancer project. This project aims at facilitating efficient self-management and management of cancer according
to the latest available clinical knowledge and the local healthcare delivery model, supporting patients and their healthcare providers in
making informed decisions on treatment choices and in managing the side effects of their therapy. The iManageCancer platform is a
comprehensive platform of interconnected mobile tools to empower cancer patients and to support them in the management of their
disease in collaboration with their doctors. The backbone of the iManageCancer platform comprises a personal health record and the
central decision support unit (CDSU). The latter offers dedicated services to the end users in combination with the apps iManageMyHealth and iSupportMyPatients. The CDSU itself is composed of the so-called Care Flow Engine (CFE) and the model repository framework (MRF). The CFE executes personalised and workflow oriented formal disease management diagrams (Care Flows). In decision
points of such a Care Flow, rules that operate on actual health information of the patient decide on the treatment path that the system
follows. Alternatively, the system can also invoke a predictive model of the MRF to proceed with the best treatment path in the diagram.
Care Flow diagrams are designed by clinical experts with a specific graphical tool that also deploys these diagrams as executable
workflows in the CFE following the Business Process Model and Notation (BPMN) standard. They are exposed as services that patients
or their doctors can use in their apps in order to manage certain aspects of the cancer disease like pain, fatigue or the monitoring of chemotherapies at home. The mHealth platform for cancer patients is currently being assessed in clinical pilots in Italy and Germany
and in several end-user workshops
How can patients and their physicians contribute to an outbreak investigation? Experiences from a nationwide listeriosis outbreak in Switzerland
How can patients and their physicians contribute to an outbreak investigation? Experiences from a nationwide listeriosis outbreak in Switzerland
p-BioSPRE-an information and communication technology framework for transnational biomaterial sharing and access
Biobanks represent key resources for clinico-genomic research and are needed to pave the way to personalised medicine. To achieve this goal, it is crucial that scientists can securely access and share high-quality biomaterial and related data. Therefore, there is a growing interest in integrating biobanks into larger biomedical information and communication technology (ICT) infrastructures. The European project p-medicine is currently building an innovative ICT infrastructure to meet this need. This platform provides tools and services for conducting research and clinical trials in personalised medicine. In this paper, we describe one of its main components, the biobank access framework p-BioSPRE (p-medicine Biospecimen Search and Project Request Engine). This generic framework enables and simplifies access to existing biobanks, but also to offer own biomaterial collections to research communities, and to manage biobank specimens and related clinical data over the ObTiMA Trial Biomaterial Manager. p-BioSPRE takes into consideration all relevant ethical and legal standards, e.g., safeguarding donors’ personal rights and enabling biobanks to keep control over the donated material and related data. The framework thus enables secure sharing of biomaterial within open and closed research communities, while flexibly integrating related clinical and omics data. Although the development of the framework is mainly driven by user scenarios from the cancer domain, in this case, acute lymphoblastic leukaemia and Wilms tumour, it can be extended to further disease entities.FP7/2007-2013/27008
CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo
Rare autosomal dominant mutations in the gene encoding the keratinocyte signaling molecule, Caspase Recruitment Domain-Containing Protein 14 (CARD14), have been associated with an increased susceptibility to psoriasis but the physiological impact of CARD14 gain-of-function mutations remains to be fully determined in vivo. Here, we report that heterozygous mice harboring a CARD14 gain-of-function mutation (Card14ΔE138) spontaneously develop a chronic psoriatic phenotype with characteristic scaling skin lesions, epidermal thickening, keratinocyte hyperproliferation, hyperkeratosis and immune cell infiltration. Affected skin of these mice is characterized by elevated expression of anti-microbial peptides, chemokines and cytokines (including Th17 cell-signature cytokines), and an immune infiltrate rich in neutrophils, myeloid cells and T-cells, reminiscent of human psoriatic skin. Disease pathogenesis was driven by the IL-23/IL-17 axis and neutralization of IL-23p19, the key cytokine in maintaining Th17 cell polarization, significantly reduced skin lesions and the expression of antimicrobial peptides and pro-inflammatory cytokines. Therefore, hyperactivation of CARD14 alone is sufficient to orchestrate the complex immunopathogenesis that drives Th17-mediated psoriasis skin disease in vivo
Vaginal microbiome and serum metabolite differences in late gestation commercial sows at risk for pelvic organ prolapse
Sow mortality attributable to pelvic organ prolapse (POP) has increased in the U.S. swine industry and continues to worsen. Two main objectives of this study were, (1) to develop a perineal scoring system that can be correlated with POP risk, and (2) identify POP risk-associated biological factors. To assess POP risk during late gestation, sows (n = 213) were scored using a newly developed perineal scoring (PS) system. Sows scored as PS1 (low), PS2 (moderate), or PS3 (high) based on POP risk. Subsequently, 1.5, 0.8, and 23.1% of sows scored PS1, PS2, or PS3, respectively, experienced POP. To identify biomarkers, serum and vaginal swabs were collected from late gestation sows differing in PS. Using GC–MS, 82 serum metabolite differences between PS1 and PS3 animals (P \u3c 0.05) were identified. Vaginal swabs were utilized for 16S rRNA gene sequencing and differences in vaginal microbiomes between PS1 and PS3 animals were detected on a community level (P \u3c 0.01) along with differences in abundances of 89 operational taxonomic units (P \u3c 0.05). Collectively, these data demonstrate that sows with greater POP risk have differential serum metabolites and vaginal microflora. Additionally, an initial and novel characterization of the sow vaginal microbiome was determined
Genetic Contribution to Alcohol Dependence: Investigation of a Heterogeneous German Sample of Individuals with Alcohol Dependence, Chronic Alcoholic Pancreatitis, and Alcohol-Related Cirrhosis
The present study investigated the genetic contribution to alcohol dependence (AD) using genome-wide association data from three German samples. These comprised patients with: (i) AD; (ii) chronic alcoholic pancreatitis (ACP); and (iii) alcohol-related liver cirrhosis (ALC). Single marker, gene-based, and pathway analyses were conducted. A significant association was detected for the ADH1B locus in a gene-based approach (puncorrected = 1.2 × 10−6; pcorrected = 0.020). This was driven by the AD subsample. No association with ADH1B was found in the combined ACP + ALC sample. On first inspection, this seems surprising, since ADH1B is a robustly replicated risk gene for AD and may therefore be expected to be associated also with subgroups of AD patients. The negative finding in the ACP + ALC sample, however, may reflect genetic stratification as well as random fluctuation of allele frequencies in the cases and controls, demonstrating the importance of large samples in which the phenotype is well assessed
Increasing abdominal pressure with and without PEEP: effects on intra-peritoneal, intra-organ and intra-vascular pressures
Intra-organ and intra-vascular pressures can be used to estimate intra-abdominal pressure. The aim of this prospective, interventional study was to assess the effect of PEEP on the accuracy of pressure estimation at different measurement sites in a model of increased abdominal pressure
- …